Company intelligence / Profile preview

Belpharma

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Belpharma is an independent, privately owned pharmaceutical and biotech company based in Luxembourg. It focuses on providing unique and targeted therapeutic solutions with a commercial portfolio that addresses unmet medical needs across more than 35 countries. Its main products include antibiotics and biologics targeting infectious diseases and oncology indications. The company operates through strategic alliances to ensure global access to its therapies.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small moleculeRecombinant protein
Industry: Biotech

Partnerships

International network of promotion & distribution agents; specific partners not named.

Beyond the preview

Go deeper on Belpharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Belpharma.

Explore the full profile